James Liao to Drug Design
This is a "connection" page, showing publications James Liao has written about Drug Design.
Connection Strength
0.614
-
The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol Rev. 2015; 67(1):103-17.
Score: 0.514
-
Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 2007 Jul; 50(1):17-24.
Score: 0.076
-
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today. 2010 Aug; 15(15-16):622-9.
Score: 0.023